Disclosure Of Earnings Per Share [Text Block]

ABIONYX Pharma - Filing #2810725

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of earnings per share [text block]
XXIX.
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
12.00
15.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
12.00
15.00
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Weighted average number of ordinary shares used in calculating basic earnings per share
29 349 981 xbrli:shares
27 967 014 xbrli:shares
Weighted average number of ordinary shares used in calculating diluted earnings per share
30 660 394 xbrli:shares
29 859 811 xbrli:shares
Increase (decrease) in number of ordinary shares issued
4 107 238 xbrli:shares
437 500 xbrli:shares
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.